Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Takeda Pharmaceutical
TAK
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$14.88
0.09
0.57%
Last update: 1:07 PM
15 minutes delayed
Get Report
Comment
Takeda Pharmaceutical (TAK) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Takeda Pharmaceutical (NYSE:TAK) Stock
Takeda Pharmaceutical Stock (NYSE: TAK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 19, 2024
Takeda To Present Additional Clinical Trial S...
Benzinga Newsdesk
Monday, September 16, 2024
Vatroslav Mateljic Appointed General Manager ...
Benzinga Newsdesk
Tuesday, September 10, 2024
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Vandana Singh
Monday, September 09, 2024
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Vandana Singh
Friday, September 06, 2024
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Vandana Singh
Monday, August 12, 2024
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
Vandana Singh
Wednesday, August 07, 2024
Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
Vandana Singh
Takeda shares are trading higher after the Eu...
Benzinga Newsdesk
The European Commission Approves Takeda's Adz...
Benzinga Newsdesk
Wednesday, July 31, 2024
Takeda 2024 Outlook, Reaffirmed: Expects Reve...
Benzinga Newsdesk
Takeda Pharmaceutical Q1 Core EPS ¥176 Up Fro...
Benzinga Newsdesk
Wednesday, July 24, 2024
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Vandana Singh
Thursday, July 18, 2024
Dr. Reddy's Signs Non-Exclusive Patent Licens...
Benzinga Newsdesk
Tuesday, July 09, 2024
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Vandana Singh
Tuesday, July 02, 2024
Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report
Lekha Gupta
Monday, June 24, 2024
FDA Expands Argenx's Vyvgart Label to Treat Rare Disorder
Zacks
Takeda's LIVTENCITY Gains Approval in Japan f...
Benzinga Newsdesk
Reported Earlier, Takeda's Mezagitamab Shows ...
Benzinga Newsdesk
Friday, June 21, 2024
Takeda Announces European Commission Approval...
Benzinga Newsdesk
Health Canada Expanded Marketing Authorizatio...
Benzinga Newsdesk
Tuesday, June 18, 2024
Takeda Pharmaceutical shares are trading lowe...
Benzinga Newsdesk
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Takeda To Present Long-Term Data From Phase 3...
Benzinga Newsdesk
Monday, June 17, 2024
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
Vandana Singh
Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies
Vandana Singh
After Takeda's Phase 3 Topline Study Results ...
Benzinga Newsdesk
Takeda Announced Topline Data From SKYLINE An...
Benzinga Newsdesk
Friday, June 14, 2024
Takeda Signs Option Agreement With Ascentage ...
Benzinga Newsdesk
Tuesday, June 11, 2024
Takeda Expands Partnership With Partners In H...
Benzinga Newsdesk
Thursday, June 06, 2024
Halozyme's ENHANZE Product Gets New Patent Grant in EU
Zacks
Monday, June 03, 2024
Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report
Akanksha Bakshi
Takeda Presents Phase 2b Results for Narcolep...
Benzinga Newsdesk
Saturday, Takeda And Pfizer Announced Present...
Benzinga Newsdesk
Friday, May 31, 2024
Takeda Gets Positive CHMP Opinion For Recombi...
Benzinga Newsdesk
Thursday, May 16, 2024
Takeda Canada Inc. Concludes Letter of Intent...
Benzinga Newsdesk
Wednesday, May 15, 2024
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
Vandana Singh
Tuesday, May 14, 2024
Scilex Holding Announce Final Court Approval ...
Benzinga Newsdesk
Monday, May 13, 2024
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Vandana Singh
AC Immune And Takeda Sign Exclusive Option an...
Benzinga Newsdesk
Thursday, May 09, 2024
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Vandana Singh
Takeda 2024 Outlook: Expects Revenue Of ¥ 4.3...
Benzinga Newsdesk
Takeda Pharmaceutical FY23 Core EPS ¥484 Down...
Benzinga Newsdesk
Friday, April 26, 2024
HUTCHMED Announces Positive CHMP Opinion For ...
Benzinga Newsdesk
Takeda Receives Positive CHMP Opinion For Fru...
Benzinga Newsdesk
Tuesday, April 23, 2024
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
Vandana Singh
Friday, April 19, 2024
Reported Earlier, Takeda Announces U.S. FDA A...
Benzinga Newsdesk
Tuesday, March 26, 2024
Takeda Announces Approval Of ADZYNMA Intraven...
Benzinga Newsdesk
Tuesday, March 19, 2024
Takeda Announces U.S. FDA Approval Of Supplem...
Benzinga Newsdesk
CENTOGENE Extends Strategic Partnership With ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch